PTLF (Petlife Pharmaceuticals) Net Margin %: 0.00% (As of Feb. 2018)


What is Petlife Pharmaceuticals Net Margin %?

Petlife Pharmaceuticals PTLF Net Margin % is 0.00% as of Feb. 2018.

Net margin is calculated as Net Income divided by its Revenue. Petlife Pharmaceuticals's Net Income for the three months ended in Feb. 2018 was $-0.43 Mil. Petlife Pharmaceuticals's Revenue for the three months ended in Feb. 2018 was $0.00 Mil. Therefore, Petlife Pharmaceuticals's net margin for the quarter that ended in Feb. 2018 was 0.00%.

The historical rank and industry rank for Petlife Pharmaceuticals's Net Margin % or its related term are showing as below:


PTLF's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.69
* Ranked among companies with meaningful Net Margin % only.

Petlife Pharmaceuticals  (OTCPK:PTLF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Petlife Pharmaceuticals Net Margin % Related Terms

Petlife Pharmaceuticals Net Margin % Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Net Margin % Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PTLF vs PCYN, YBAO, BKIT: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Petlife Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Petlife Pharmaceuticals Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Petlife Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Petlife Pharmaceuticals's Net Margin % falls into.


Petlife Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Petlife Pharmaceuticals's Net Margin for the fiscal year that ended in Aug. 2017 is calculated as

Net Margin=Net Income (A: Aug. 2017 )/Revenue (A: Aug. 2017 )
=-23.257/0
= %

Petlife Pharmaceuticals's Net Margin for the quarter that ended in Feb. 2018 is calculated as

Net Margin=Net Income (Q: Feb. 2018 )/Revenue (Q: Feb. 2018 )
=-0.427/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Petlife Pharmaceuticals (PTLF) has a Net Margin % of 0.00% as of Feb. 2018. Net margin is the ratio of total net income to net sales. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' Net Margin % too high?
Petlife Pharmaceuticals' current Net Margin % is 0.00%.
How does Petlife Pharmaceuticals' Net Margin % compare to PCYN and YBAO?
Petlife Pharmaceuticals' Net Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median Net Margin % is 5.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.69, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Petlife Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Petlife Pharmaceuticals's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current Net Margin % is 0.00% as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.